Breast Artery Calcification (BAC) and Female Cardiovascular Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age55-65
SponsorNorthwell Health

About this trial

The investigators are recruiting women with and without Breast Artery Calcification (BAC) on their mammograms. Each participant in the study will undergo bloodwork at a Northwell Health lab, a cardiac CT scan, and fill out some brief questionnaires. Results will be shared with the respective participant. At the conclusion of the study, statistical analyses will be performed to further understand the associations between BAC and cardiovascular markers.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

female

55-65 years old

Disqualifiers

ischemia

diabetes

statin or cholesterol lowering medicine use

cardiovascular disease: coronary artery disease, heart failure, arrhythmia, significant valvular disease

Trial population

Potential subjects will be recruited from all women who underwent a mammogram at Northwell Health.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Cardiac CT Scan

    Diagnostic test

    A non-contrast Cardiac CT Scan is a routine exam and a non-invasive scan to look for coronary artery calcium.

  • Bloodwork

    Diagnostic test

    Blood will be drawn at a Northwell Lab. Participants will need to fast before the collection. Cholesterol levels, blood sugar (hemoglobin A1C), and markers for inflammation and kidney function will be analyzed.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: BAC = 0 Group2 interventions
Group B: BAC >0 Group2 interventions

Trial outcomes

Primary outcomes

1

Coronary Artery Calcium Score

This result is obtained by the Cardiac CT Scan.

Time frame
7 days

Secondary outcomes

1

Incidence of Dyslipidemia

Obtained through laboratory testing

Time frame
3 days
2

High-sensitivity C-reactive protein elevation

Obtained through laboratory testing

Time frame
3 days
3

Lp(a) elevation

Obtained through laboratory testing

Time frame
3 days
4

HbA1c

Obtained through laboratory testing

Time frame
3 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.